FDA Guidance: What it Means for AMD Trials
Industry leaders discuss the shifts in clinical trial designs and their recent interactions with the FDA.
Nadia K. Waheed, MD, MPH; Ramiro Ribeiro, MD, PhD; Victor Chong, MD, MBA, FARVO; Lanita Scott, MD; and David J. Tanzer, MD
